NCT01222351View on ClinicalTrials.gov

Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172

NACompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

October 22, 2014

Study Completion Date

October 22, 2014

Conditions
Late Onset Alzheimer Disease
Interventions
DRUG

BAY 94-9172 (Florbetaben)

Measure of brain amyloid load using BAY 94-9172 PET/CT

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

National Institute on Aging (NIA)

NIH

lead

New York State Psychiatric Institute

OTHER